Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial.
- DOI
- 10.1038/s41591-024-03406-8
- Published
- 2025 Mar
- Container
- Nature medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41591-024-03406-8,
title = {Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial.},
author = {Brennan PN and MacMillan M and Manship T and Moroni F and Glover A and Troland D and MacPherson I and Graham C and Aird R and Semple SIK and Morris DM and Fraser AR and Pass C and McGowan NWA and Turner ML and Manson L and Lachlan NJ and Dillon JF and Kilpatrick AM and Campbell JDM and Fallowfield JA and Forbes SJ},
year = {2025},
journal = {Nature medicine},
doi = {10.1038/s41591-024-03406-8},
url = {https://doi.org/10.1038/s41591-024-03406-8}
}RIS
TY - JOUR TI - Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial. AU - Brennan PN AU - MacMillan M AU - Manship T AU - Moroni F AU - Glover A AU - Troland D AU - MacPherson I AU - Graham C AU - Aird R AU - Semple SIK AU - Morris DM AU - Fraser AR AU - Pass C AU - McGowan NWA AU - Turner ML AU - Manson L AU - Lachlan NJ AU - Dillon JF AU - Kilpatrick AM AU - Campbell JDM AU - Fallowfield JA AU - Forbes SJ PY - 2025 JO - Nature medicine DO - 10.1038/s41591-024-03406-8 UR - https://doi.org/10.1038/s41591-024-03406-8 ER -
APA
PN, B., M, M., T, M., F, M., A, G., D, T., I, M., C, G., R, A., SIK, S., DM, M., AR, F., C, P., NWA, M., ML, T., L, M., NJ, L., JF, D., AM, K., JDM, C., JA, F., & SJ, F. (2025). Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial.. Nature medicine. https://doi.org/10.1038/s41591-024-03406-8
Source records
- pubmed · retrieved 2026-09-27T01:29:58.861Z